Latest News for: nektar

Edit

NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors

The Eagle-Tribune 28 Apr 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nektar (NKTR) To Contact Him Directly To Discuss Their Options ... .
Edit

NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May

The Eagle-Tribune 28 Apr 2026
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Nektar Therapeutics (NASDAQ. NKTR) securities of a pending securities class action ... .
Edit

NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors that a Class ...

Nasdaq Globe Newswire 28 Apr 2026
Bragar Eagel & Squire, P.C.�Litigation PartnerBrandon Walker�Encourages Investors Who Suffered Losses In Nektar (NKTR) To Contact Him Directly To Discuss Their Options ... .
Edit

Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

PR Newswire 27 Apr 2026
Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ.
Edit

NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit

PR Newswire 27 Apr 2026
Why. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ ... To join the Nektar class action, go to https.//rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.
Edit

Annual Report (Form ARS) (Nektar Therapeutics)

Public Technologies 24 Apr 2026
Nektar Therapeutics published this content on April 24, 2026, and is solely ...
Edit

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy

Enid News & Eagle 24 Apr 2026
LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased ... .
Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Nektar Therapeutics)

Public Technologies 24 Apr 2026
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 14A ... (Amendment No. ) ... Nektar Therapeutics ... Nektar Therapeutics published this content on April 24, 2026, and is solely responsible for the information contained herein.
×